Lenschow DJ, Zeng Y, Thistlethwaite JR, et al. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg. Science. 1992;257(5071):789–92.

Article  CAS  PubMed  Google Scholar 

Perez VL, Van Parijs L, Biuckians A, et al. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity. 1997;6(4):411–7.

Article  CAS  PubMed  Google Scholar 

Kowalski RJ, Post DR, Mannon RB, et al. Assessing relative risks of infection and rejection: a meta-analysis using an immune function assay. Transplantation. 2006;82(5):663–8.

Article  PubMed  Google Scholar 

Montano-Loza AJ, Rodríguez-Perálvarez ML, Pageaux GP, et al. Liver transplantation immunology: Immunosuppression, rejection, and immunomodulation. J Hepatol. 2023;78(6):1199–215.

Article  PubMed  Google Scholar 

Mehra NK, Baranwal AK. Clinical and immunological relevance of antibodies in solid organ transplantation. Int J Immunogenet. 2016;43(6):351–68.

Article  CAS  PubMed  Google Scholar 

Fuehner T, Benden C, Gottlieb J. Initial immunosuppression and managing rejection. Intensive Care Med. 2019;45:388–90.

Article  PubMed  Google Scholar 

Gauthier JM, Ruiz-Pérez D, Li W, et al. Diagnosis, pathophysiology and experimental models of chronic lung allograft rejection. Transplantation. 2018;102(9):1459–66.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Volkan-Salanci B, Erbas B. Imaging in renal transplants: an update. Semin Nucl Med. 2021;51(4):364–79.

Article  PubMed  Google Scholar 

Cooper JE. Evaluation and treatment of acute rejection in kidney allografts. Clin J Am Soc Nephrol. 2020;15(3):430–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Knight SR, Thorne A, Faro MLL. Donor-specific cell-free DNA as a biomarker in solid organ transplantation. A systematic review. Transplantation. 2019;103(2):273–83.

Article  CAS  PubMed  Google Scholar 

From AM, Maleszewski JJ, Rihal CS. Current status of endomyocardial biopsy. Mayo Clin Proc. 2011;86(11):1095–102.

Article  PubMed  PubMed Central  Google Scholar 

Parajuli S, Zhong W, Pantha M, et al. The trend of serum creatinine does not predict follow-up biopsy findings among kidney transplant recipients with antibody-mediated rejection. Transplant Direct. 2023;9(6): e1489.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hanssen O, Erpicum P, Lovinfosse P, et al. Non-invasive approaches in the diagnosis of acute rejection in kidney transplant recipients. Part I. In vivo imaging methods. Clin Kidney J. 2017;10(1):97–105.

CAS  PubMed  Google Scholar 

Olymbios M, Kwiecinski J, Berman DS, et al. Imaging in heart transplant patients. JACC-Cardiovasc Imag. 2018;11(10):1514–30.

Article  Google Scholar 

Alasfar S, Kodali L, Schinstock CA. Current therapies in kidney transplant rejection. J Clin Med. 2023;12(15):4927.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Menon MC, Murphy B, Heeger PS. Moving biomarkers toward clinical implementation in kidney transplantation. J Am Soc Nephrol. 2017;28(3):735–47.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Naesens M, Anglicheau D. Precision transplant medicine: biomarkers to the rescue. J Am Soc Nephrol. 2018;29(1):24–34.

Article  CAS  PubMed  Google Scholar 

Fernando JJ, Biswas R, Biswas L. Non-invasive molecular biomarkers for monitoring solid organ transplantation: a comprehensive overview. Int J Immunogenet. 2024;51(2):47–62.

Article  CAS  PubMed  Google Scholar 

Khachatoorian Y, Khachadourian V, Chang E, et al. Noninvasive biomarkers for prediction and diagnosis of heart transplantation rejection. Transplant Rev-Orlan. 2021;35(1): 100590.

Article  Google Scholar 

Klinkhammer BM, Lammers T, Mottaghy FM, et al. Non-invasive molecular imaging of kidney diseases. Nat Rev Nephrol. 2021;17(10):688–703.

Article  PubMed  PubMed Central  Google Scholar 

Working GBD. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69(3):89–95.

Article  Google Scholar 

Lo DJ, Kaplan B, Kirk AD. Biomarkers for kidney transplant rejection. Nat Rev Nephrol. 2014;10(4):215–25.

Article  CAS  PubMed  Google Scholar 

Roedder S, Vitalone M, Khatri P, et al. Biomarkers in solid organ transplantation: establishing personalized transplantation medicine. Genome Med. 2011;3:37.

Article  PubMed  PubMed Central  Google Scholar 

Oellerich M, Shipkova M, Asendorf T, et al. Absolute quantification of donor-derived cell-free DNA as a marker of rejection and graft injury in kidney transplantation: results from a prospective observational study. Am J Transplant. 2019;19(11):3087–99.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Coutance G, Desiré E, Duong Van Huyen JP. A review of biomarkers of cardiac allograft rejection: toward an integrated diagnosis of rejection. Biomolecules. 2022;12(8):1135.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Duquesnoy RJ. Are we ready for rpitope-based HLA matching in clinical organ transplantation? Transplantation. 2017;101(8):1755–65.

Article  PubMed  Google Scholar 

Joher N, Matignon M, Grimbert P. HLA desensitization in solid organ transplantation: anti-CD38 to across the immunological barriers. Front Immunol. 2021;12: 688301.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lorenz EC, Smith BH, Liang Y, et al. Increased pretransplant inflammatory biomarkers predict death with function after kidney transplantation. Transplantation. 2024;108(12):2434–45.

Article  CAS  Google Scholar 

Van den Bosch TPP, Hilbrands LB, Kraaijeveld R, et al. Pretransplant numbers of CD16+ monocytes as a novel biomarker to predict acute rejection after kidney transplantation: a pilot study. Am J Transplant. 2017;17(10):2659–67.

Article  PubMed  Google Scholar 

Baryła M, Skrzycki M, Danielewicz R, et al. Protein biomarkers in assessing kidney quality before transplantation-current status and future perspectives. Int J Mol Med. 2024;54(6):107.

Article  PubMed  PubMed Central  Google Scholar 

Mandel P, Metais P. Nucleic acids of human blood plasma. Compte Rendu des Seances de la Societe de Biologie. 1948;142:241–3.

CAS  Google Scholar 

Andrade-Campos MM, Salar A, Sanchez-Gonzalez B, et al. Assessment of cell-free DNA (cfDNA) in 221 patients with lymphoproliferative malignancies at diagnosis and during follow-up. Blood. 2019;134(Suppl 1):492.

Article  Google Scholar 

De Vlaminck I. The proportion of donor-specific cell-free DNA in blood as a marker of transplant rejection: not an absolute. Clin Chem. 2020;66(10):1257–8.

Article  PubMed  Google Scholar 

De Vlaminck I, Valantine HA, Snyder TM, et al. Circulating cell-free DNA enables noninvasive diagnosis of heart transplant rejection. Sci Transl Med. 2014;6(241):241ra77.